About Jubilant Life Sciences
Jubilant Life Sciences is a company based in Noida (India) founded in 1978 by Hari Bhartia. The company has 1,055 employees as of March 30, 2024. Jubilant Life Sciences has completed 5 acquisitions, including Bestcro, DRAXIS Health and Hollister-Stier. Jubilant Life Sciences offers products and services including Pharmaceuticals, Drug Discovery Solutions, Proprietary Novel Drugs, and Specialty Chemicals. Jubilant Life Sciences operates in a competitive market with competitors including Akums, Recipharm, Unither, Nectar Lifesciences and CoreRx, among others.
- Headquarter Noida, India
- Employees 1055 as on 30 Mar, 2024
- Founders Hari Bhartia
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Jubilant Pharmova Limited
- Jurisdiction U P, Uttar Pradesh, India
-
Annual Revenue
$759.9 M (USD)2.91as on Mar 31, 2023
-
Net Profit
-$7.8 M (USD)-115.71as on Mar 31, 2023
-
EBITDA
$93.33 M (USD)-32.87as on Mar 31, 2023
-
Latest Funding Round
$86.11 M (USD), Post-IPO
Mar 01, 2010
- Investors
-
Employee Count
1055
as on Mar 30, 2024
-
Investments & Acquisitions
Bestcro
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Jubilant Life Sciences
Jubilant Life Sciences offers a comprehensive portfolio of products and services, including Pharmaceuticals, Drug Discovery Solutions, Proprietary Novel Drugs, and Specialty Chemicals.
Products for addressing unmet health needs through research and manufacturing.
Services focused on developing innovative drug solutions for global markets.
Specialized drugs created to meet specific health challenges affordably.
Chemicals for nutrition and health applications in various industries.
Funding Insights of Jubilant Life Sciences
Investors in Jubilant Life Sciences
Jubilant Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Locked | Locked | Locked |
Investor details for Jubilant Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Jubilant Life Sciences
Jubilant Life Sciences has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Bestcro, DRAXIS Health and Hollister-Stier.
Investment portfolio details for Jubilant Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Research consulting services are provided for pharmaceutical and biotech sectors.
|
Locked | Locked | 1996 | Locked | |
|
Radiopharmaceuticals are developed and manufactured for medical imaging applications.
|
Locked | Locked | 1995 | Locked | |
|
Full-service clinical research organization software and services are provided.
|
Locked | Locked | 1993 | Locked |
Complete acquisition details for Jubilant Life Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Jubilant Life Sciences
Detailed financials for Jubilant Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jubilant Life Sciences Comparisons
Peer comparison for Jubilant Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Jubilant Life Sciences
Jubilant Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Recipharm, Unither, Nectar Lifesciences and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Jubilant Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jubilant Life Sciences
Complete news archive for Jubilant Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jubilant Life Sciences
Jubilant Life Sciences was founded in 1978 and raised its 1st funding round 25 years after it was founded.
Jubilant Life Sciences is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
As of Mar 30, 2024, the latest employee count at Jubilant Life Sciences is 1,055.
Annual revenue of Jubilant Life Sciences is $759.9M as on Mar 31, 2023.
Founded in 1978, operations are conducted in the pharmaceutical and life sciences sectors from Noida, India. APIs, solid dosage formulations, radiopharmaceuticals, and allergy therapy products are manufactured and supplied, alongside contract services for sterile injectables and drug discovery. Advanced intermediates, fine ingredients, and nutritional products are also produced. Facilities are maintained in India and North America, with products distributed to over 100 countries across North America, Europe, India, and China.
Jubilant Life Sciences's top competitors include Akums, Nectar Lifesciences and Windlas.
Jubilant Life Sciences offers Pharmaceuticals, Drug Discovery Solutions, Proprietary Novel Drugs, and Specialty Chemicals.
Jubilant Life Sciences has made 5 acquisitions, including Bestcro, DRAXIS Health, and Hollister-Stier.
Jubilant Life Sciences has 1 investor. Key investors include General Atlantic.